AAAAAA

   
Results: 1-14 |
Results: 14
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
Authors: Crivellari, D Pagani, O Veronesi, A Lombardi, D Nole, F Thurlimann, B Hess, D Borner, M Bauer, J Martinelli, G Graffeo, R Sessa, C Goldhirsch, A
Citation: D. Crivellari et al., High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel, ANN ONCOL, 12(3), 2001, pp. 353-356
Fourteen-day infusion of ifosfamide in the management of advanced breast cancer refractory to protracted continuous infusion of 5-fluorouracil
Authors: Di Lauro, V Spazzapan, S Lombardi, D Paolello, C Scuderi, C Crivellari, D Magri, MD Veronesi, A
Citation: V. Di Lauro et al., Fourteen-day infusion of ifosfamide in the management of advanced breast cancer refractory to protracted continuous infusion of 5-fluorouracil, TUMORI, 87(1), 2001, pp. 27-29
Dose-finding and pharmacologic study of chronic oral idarubicin therapy inmetastatic breast cancer patients
Authors: Toffoli, G Sorio, R Aita, P Crivellari, D Corona, G Bearz, A Robieux, I Colussi, AM Stocco, F Boiocchi, M
Citation: G. Toffoli et al., Dose-finding and pharmacologic study of chronic oral idarubicin therapy inmetastatic breast cancer patients, CLIN CANC R, 6(6), 2000, pp. 2279-2287
Determination of tamoxifen and its metabolites in the endometrial tissue of long-term treated women
Authors: Giorda, G Franceschi, L Crivellari, D Magri, MD Veronesi, A Scarabelli, C Furlanut, M
Citation: G. Giorda et al., Determination of tamoxifen and its metabolites in the endometrial tissue of long-term treated women, EUR J CANC, 36, 2000, pp. S88-S89
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study
Authors: Pagani, O Sessa, C Nole, F Crivellari, D Lombardi, D Thurlimann, B Hess, D Borner, M Bauer, J Martinelli, G Graffeo, R Zucchetti, M D'Incalci, M Goldhirsch, A
Citation: O. Pagani et al., Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study, ANN ONCOL, 11(8), 2000, pp. 985-991
Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancer
Authors: Lombardi, D Magri, MD Crivellari, D Spazzapan, S Paolello, C De Cicco, M Di Lauro, V Scuderi, C Veronesi, A
Citation: D. Lombardi et al., Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancer, ANN ONCOL, 11(8), 2000, pp. 1041-1043
MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)
Authors: Toffoli, G Veronesi, A Boiocchi, M Crivellari, D
Citation: G. Toffoli et al., MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF), ANN ONCOL, 11(3), 2000, pp. 373-374
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII
Authors: Crivellari, D Bonetti, M Castiglione-Gertsch, M Gelber, RD Rudenstam, CM Thurlimann, B Price, KN Coates, AS Hurny, C Bernhard, J Lindtner, J Collins, J Senn, HJ Cavalli, F Forbes, J Gudgeon, A Simoncini, E Cortes-Funes, H Veronesi, A Fey, M Goldhirsch, A
Citation: D. Crivellari et al., Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII, J CL ONCOL, 18(7), 2000, pp. 1412-1422
Continuous infusion fluorouracil in the management of advanced breast cancer: A phase II study
Authors: Crivellari, D Magri, MD Buonadonna, A Lombardi, D Paolello, C De Cicco, M Fantin, D Veronesi, A
Citation: D. Crivellari et al., Continuous infusion fluorouracil in the management of advanced breast cancer: A phase II study, TUMORI, 86(1), 2000, pp. 42-45
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Authors: Aebi, S Gelber, S Castiglione-Gertsch, M Gelber, RD Collins, J Thurlimann, B Rudenstam, CM Lindtner, J Crivellari, D Cortes-Funes, H Simoncini, E Werner, ID Coates, AS Goldhirsch, A
Citation: S. Aebi et al., Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?, LANCET, 355(9218), 2000, pp. 1869-1874
Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer
Authors: Pagani, O Sessa, C Martinelli, G Crivellari, D Buonadonna, A Thurlimann, B Hess, D Borner, M Bauer, J Zampino, G Zimatore, M Graffeo, R Riva, A Goldhirsch, A
Citation: O. Pagani et al., Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer, ANN ONCOL, 10(5), 1999, pp. 539-545
BRCA1 and BRCA2 genes: Role in hereditary breast and ovarian cancer in Italy
Authors: Santarosa, M Dolcetti, R Magri, MD Crivellari, D Tibiletti, MG Gallo, A Tumolo, S Della Puppa, L Furlan, D Boiocchi, M Viel, A
Citation: M. Santarosa et al., BRCA1 and BRCA2 genes: Role in hereditary breast and ovarian cancer in Italy, INT J CANC, 83(1), 1999, pp. 5-9
Anthracycline dose and liver dysfunction
Authors: Cannizzaro, R Crivellari, D Robieux, I Sorio, R Buonadonna, A
Citation: R. Cannizzaro et al., Anthracycline dose and liver dysfunction, BR J CANC, 79(11-12), 1999, pp. 1943-1943
Does the information level of cancer patients correlate with quality of life? A prospective study
Authors: Annunziata, MA Foladore, S Magri, MD Crivellari, D Feltrin, A Bidoli, E Veronesi, A
Citation: Ma. Annunziata et al., Does the information level of cancer patients correlate with quality of life? A prospective study, TUMORI, 84(6), 1998, pp. 619-623
Risultati: 1-14 |